Clinical trials
Androgenetic Alopecia (AGA) clinical trials
Below are recruiting androgenetic alopecia (aga) clinical trials, each written for real people, not researchers. We’re tracking 12 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05888922RecruitingPhase 3
Oral minoxidil for female hair thinning: a Phase 3 study
This Phase 3 trial tests whether a 1 mg oral minoxidil pill helps improve hair thinning in women and checks its safety. If you match the study’s hair-loss pattern and can follow the visit and medication routine, you may be able to join.
Bad BentheimAges 18 years+ - NCT07693244RecruitingPhase 2
Exosome therapy for male pattern baldness
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
BeijingAges 18–55 - NCT07012486RecruitingEarly Phase 1
Dihydroartemisinin for female hair loss
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT07079657Recruiting
Thulium laser and growth factors for hair loss
This trial tests whether a special laser combined with growth factor injections can help regrow hair in people with common hereditary hair loss (androgenetic alopecia). It aims to find a new treatment option that may work better than current methods.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT07080931RecruitingPhase 3
Minoxidil foam for female hair loss
This trial tests a 5% minoxidil foam to treat female pattern hair loss. It may help women who have been diagnosed with this condition and have mild to moderate hair thinning.
BeijingAges 18 years+ - NCT07317544RecruitingPhase 1/Phase 2
Study of a new hair loss treatment in healthy adults
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
Sydney, New South WalesAges 18–65 - NCT07327359RecruitingPhase 1/Phase 2
Study of OLX72021 for male pattern baldness
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
Camberwell, VictoriaAges 18–59 - NCT07335367RecruitingPhase 2
PRP and Botox for hair loss: a study
This trial tests whether combining platelet-rich plasma (PRP) injections with botulinum toxin type A (Botox) can help regrow hair in people with male or female pattern baldness. It aims to see if this combination is safe and effective for treating androgenetic alopecia.
Guangzhou, GuangdongAges 18–60 - NCT07370519RecruitingPhase 2
Probiotic lotion for hair loss
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
Shenzhen, GuangdongAges 18–60 - NCT07536100Recruiting
New Hair Growth Serum vs. Minoxidil for Hair Loss
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Bangkok, BangkokAges 18 years+ - NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
Xinxiang, HenanAges 20–65 - NCT06764329Enrolling by invitationPhase 1/Phase 2
Stem cell therapy for male hair loss
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
RawalpindiAges 20–59
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for androgenetic alopecia (aga)?
- Yes. Clin2 currently lists 12 recruiting androgenetic alopecia (aga) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a androgenetic alopecia (aga) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a androgenetic alopecia (aga) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.